Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ryu, JR | - |
dc.contributor.author | Lee, J | - |
dc.contributor.author | Choo, S | - |
dc.contributor.author | Yoon, SH | - |
dc.contributor.author | Woo, ER | - |
dc.contributor.author | Yu, YG | - |
dc.date.accessioned | 2024-01-21T16:13:31Z | - |
dc.date.available | 2024-01-21T16:13:31Z | - |
dc.date.created | 2021-09-03 | - |
dc.date.issued | 1998-12-31 | - |
dc.identifier.issn | 1016-8478 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/142641 | - |
dc.description.abstract | The transmembrane protein of HIV-1, gp41, mediates fusion between membranes of the virus and target cell. Strong interaction between the helical regions in the ectodomain of gp41 has been exploited to develop a method that can detect a potential inhibitor against gp41, The N-terminus coiled-coil or the C-terminus helical sequences within the ectodomain of gp41 were inserted into the C-terminus of thioredoxin (Trx) or glutathione S-transferase (GST) to generate the fusion proteins, Trx-N and GST-C, respectively. The inserted sequences of GST-C and Trx-N cause the two proteins to interact with each other and to form a complex, Furthermore, GST-C binds specifically to the surface-coated Trx-N, and the amount of attached GST-C is detected by an ELISA assay using anti-GST antibodies, Peptides derived from the helical regions of gp41 compete with GST-C for binding to Trx-N as well as prevent the gp41-mediated cell fusion, This in vitro assay system can be applied to screening compounds that have an inhibitory activity against gp41. | - |
dc.language | English | - |
dc.publisher | SPRINGER-VERLAG SINGAPORE PTE LTD | - |
dc.subject | IMMUNODEFICIENCY-VIRUS TYPE-1 | - |
dc.subject | ENVELOPE GLYCOPROTEIN | - |
dc.subject | FUSION MECHANISM | - |
dc.subject | MEMBRANE-FUSION | - |
dc.subject | VIRAL FUSION | - |
dc.subject | SOLUBLE CD4 | - |
dc.subject | PEPTIDE | - |
dc.subject | DOMAIN | - |
dc.subject | ACTIVATION | - |
dc.subject | POLYMERASE | - |
dc.title | Development of an in vitro assay system for screening of gp41 inhibitory compounds | - |
dc.type | Article | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | MOLECULES AND CELLS, v.8, no.6, pp.717 - 723 | - |
dc.citation.title | MOLECULES AND CELLS | - |
dc.citation.volume | 8 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 717 | - |
dc.citation.endPage | 723 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000077860000011 | - |
dc.identifier.scopusid | 2-s2.0-0032585364 | - |
dc.relation.journalWebOfScienceCategory | Biochemistry & Molecular Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | IMMUNODEFICIENCY-VIRUS TYPE-1 | - |
dc.subject.keywordPlus | ENVELOPE GLYCOPROTEIN | - |
dc.subject.keywordPlus | FUSION MECHANISM | - |
dc.subject.keywordPlus | MEMBRANE-FUSION | - |
dc.subject.keywordPlus | VIRAL FUSION | - |
dc.subject.keywordPlus | SOLUBLE CD4 | - |
dc.subject.keywordPlus | PEPTIDE | - |
dc.subject.keywordPlus | DOMAIN | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | POLYMERASE | - |
dc.subject.keywordAuthor | gp41 | - |
dc.subject.keywordAuthor | HIV | - |
dc.subject.keywordAuthor | in vitro assay | - |
dc.subject.keywordAuthor | inhibitor | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.